Immutep Ltd ADR share price logo

Immutep Ltd ADR Share Price

NASDAQ: IMMP

Small Cap

$0.32

+0.01

(+2.34%)

as on

Immutep Ltd ADR Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    $0.30
    $0.32
    downward going graph

    6.25%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.29
    $3.53
    downward going graph

    8.50%

    Downside

    1003.09%

    Upside

    downward going graph

Immutep Ltd ADR share price movements today

Previous Close
$0.31
Open
$0.31
Volume
1.5M
Day's Low - High
$0.30 - $0.32
52 Week Low - High
$0.29 - $3.53

Immutep Ltd ADR Historical Returns

1 Month Return
-35.04 %
3 Month Return
-89.61 %
1 Year Return
-79.15 %
3 Year Return
-80.2 %
5 Year Return
-90.66 %

Immutep Ltd ADR Stock Fundamentals & Key Indicators

Check Immutep Ltd ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.4M

EPS (TTM)

-0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-82.4M

Revenue (TTM)

7.9M

Profit Margin

0.00%

Return On Equity TTM

-61.85%

Immutep Ltd ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Ltd ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immutep Ltd ADR image
Immutep Ltd ADR
BUY$46.4M-90.66%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$45.0B144.14%145.058.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.0B100.94%28.9832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA123.515.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B52.74%17.9931.41%

Stock Returns calculator for Immutep Ltd ADR Stock including INR - Dollar returns

The Immutep Ltd ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immutep Ltd ADR investment value today

Current value as on today

₹22,924

Returns

-₹77,076

(-77.08%)

Returns from Immutep Ltd ADR Stock

-₹78,808 (-78.81%)

Dollar Impact

₹1,732 (+1.73%)

Analyst Recommendation on Immutep Ltd ADR Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Ltd ADR. Average target price of $1

Immutep Ltd ADR Share Price Target

Get share price movements and forecasts by analysts on Immutep Ltd ADR.

What analysts predicted

68%UPSIDE

Target Price

$1

Current Price

$0.32

Analyzed by

9 Analysts

Target

$1.00

Immutep Ltd ADR target price $1, a slight upside of 68% compared to current price of $0.32. According to 9 analysts rating.

Immutep Ltd ADR Stock’s Investor Sentiment and Interest

Search interest for Immutep Ltd ADR Stock has increased by 207% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:207% versus previous 30 day period

Immutep Ltd ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
1
1
2
1
1
3
1
6
Gross Profit
0
0
1
-19
-19
-22
-34
-40
Operating Income
-23
-21
-43
-44
-44
-51
-74
-46
EBITDA
-20
-19
-22
-22
-22
-26
-36
-44
Interest Expense
0
0
0
0
0
-
-
0
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-20
-19
-21
-21
-21
-22
-39
-44
Income Tax Expense
0
0
0
21
21
-
-
-
Net Income
-13
-19
-21
-21
-21
-22
-39
-44
Net Profit Margin
-1223.54%
-1058.85%
-1005.72%
-1241.29%
-1241.29%
-710.92%
-2059.84%
-744.36%

Immutep Ltd ADR Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
3
1
0
5
2
0
2
2
5
Gross Profit
-5
1
-5
-11
-10
-10
-1
0
-25
-56
Operating Income
-61
-9
-11
-20
-16
-31
-33
-77
-88
-126
EBITDA
-61
-8
-10
-16
-11
-17
-31
-39
-44
-62
Interest Expense
0
-
-
-
0
0
0
0
0
-
Depreciation
-
1
1
1
2
2
2
-
-
-
Income Before Tax
-63
-10
-12
-18
-13
-29
-32
-39
-42
-61
Income Tax Expense
-1
0
0
-2
0
0
0
0
0
-
Net Income
-45
-7
-9
-11
-9
-22
-22
-26
-28
-61
Net Profit Margin
-35426.72%
-221.89%
-484.55%
-11640.01%
-179.90%
-774.12%
-18906.51%
-1138.04%
-1111.87%
-1218.02%

Immutep Ltd ADR Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Net Income
-19
-21
-
-21
-21
-22
-
-39
-44
Operating Cash Flow
-17
-17
-
-16
-7
-28
-
-33
-28
Investing Cash Flow
0
0
-
-
-20
-30
-
24
34
Financing Cash Flow
38
0
0
95
95
0
0
0
0
Change in Cash
68
-6
-8
58
66
-46
-
-73
6

Immutep Ltd ADR Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-9
-12
-18
-13
-29
-32
-39
-42
-61
Operating Cash Flow
-8
-7
-15
-10
-17
-30
-35
-34
-62
Investing Cash Flow
0
0
0
0
0
0
0
-21
-38
Financing Cash Flow
0
18
8
20
52
50
76
95
0
Change in Cash
-8
11
-6
9
34
19
43
38
-94

Global Institutional Holdings in Immutep Ltd ADR

Funds
Holdings
LPL Financial Corp
0.02%
Dimensional Fund Advisors, Inc.
0.02%
BlackRock Inc
0.39%
Geode Capital Management, LLC
0.01%
LPL Financial Corp
0.02%
See all

Immutep Ltd ADR News & Key Events

    Insights on Immutep Ltd ADR

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 1.89M → 6.02M (in $), with an average increase of 68.5% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 143.9%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 44.2% return, outperforming this stock by 123.8%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, IMMP stock has moved down by -12.6%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 7 quarters, -19.27M → -44.85M (in $), with an average decrease of 17.5% per quarter

    About Immutep Ltd ADR

    Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.
    OrganisationImmutep Ltd ADR
    HeadquartersAustralia Square, Sydney, NSW, Australia, 2000
    IndustryBiotechnology
    CEOMr. Marc Voigt
    E-voting on sharesClick here to vote

    Key Management of Immutep Ltd ADR

    Name

    Title

    Dr. Stephan Winckels M.D., Ph.D.

    Chief Medical Officer

    Ms. Indira Naidu

    Joint Company Secretary

    Mr. Marc Voigt

    CEO, MD, CFO, Chief Business Officer & Executive Director

    Ms. Deanne Miller LLB

    COO, General Counsel & Joint Company Secretary

    Dr. Frederic Triebel M.D., Ph.D.

    Chief Scientific Officer & Executive Director

    Mr. Christian Mueller BBA, MSc.

    Chief Development Officer

    FAQs

    What is Immutep Ltd ADR share price today?

    Immutep Ltd ADR share price today is $0.32 as on at the close of the market. Immutep Ltd ADR share today touched a day high of $0.32 and a low of $0.3.

    What is the 52 week high and 52 week low for Immutep Ltd ADR share?

    Immutep Ltd ADR share touched a 52 week high of $3.53 on and a 52 week low of $0.29 on . Immutep Ltd ADR stock price today i.e. is closed at $0.32,which is 90.93% down from its 52 week high and 9.29% up from its 52 week low.

    What is Immutep Ltd ADR's market capitalisation today?

    Immutep Ltd ADR market capitalisation is $0.00T as on .

    How to invest in Immutep Ltd ADR Stock (IMMP) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immutep Ltd ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Ltd ADR Shares that will get you 4.6875 shares as per Immutep Ltd ADR share price of $0.32 per share as on April 15, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Immutep Ltd ADR Stock (IMMP) from India?

    Indian investors can start investing in Immutep Ltd ADR (IMMP) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹930.82 in Immutep Ltd ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Immutep Ltd ADR share’s latest price of $0.32 as on April 15, 2026 at 1:29 am IST, you will get 31.2500 shares of Immutep Ltd ADR. Learn more about fractional shares .

    What are the returns that Immutep Ltd ADR has given to Indian investors in the last 5 years?

    Immutep Ltd ADR stock has given -90.66% share price returns and 24.21% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?